Flemish cCMV registry: threshold variability by Dhooge, Ingeborg et al.
Neus-, keel- en oorheelkunde, Hoofd- en halschirurgie 
Neus-, keel- en oorheelkunde, Hoofd- en halschirurgie 
Flemish cCMV registry:  
Threshold variability 
 
Ingeborg Dhooge, MD, PhD 
Julie Goderis, MD 
Freya Swinnen, MA, PhD 
Dept. Otorhinolaryngology  
Ghent University Hospital, Belgium 
Neus-, keel- en oorheelkunde, Hoofd- en halschirurgie 
Prospective follow-up study (2007 -   
 








• Pregnancy, diagnosis and neonatal investigations  
• Treatment with Ganciclovir/Valganciclovir 






Congenital CMV Registry 
Ghent UH St. Augustinus Hospital Wilrijk 
Antwerp UH Queen Paola Child Hospital Wilrijk 
Leuven UH St. Jan Hospital Bruges 
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cCMV associated hearing loss 
cCMV associated hearing loss 
 
Exclusively sensorineural 
70% severe to profound 
Uni- and bilateral 
15% delayed onset HL 
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Definition of symptomatic cCMV 
Symptomatic = Abnormality on one or more neonatal investigations:
  
  
Physical examination jaundice, petechial rash, 
hepatosplenomegaly, microcephaly, 
dysmaturity, seizures 
Central imaging  
(US/CT/MRI) 
 
calcifications, periventricular cysts, white 
matter hyperintensity, cortical atrophy, 
ventriculomegaly, gyration disorders, ..  
Hearing test sensorineural hearing loss 
Ophthalmologic 
examination 
chorioretinitis, visual impairment, cataract 
Blood tests thrombopenia, conjugated hyperbilirubinemia, 
elevated hepatic transaminases  
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Results August 2014 
August 2014:   491 children in the registry 
        379 included in the analysis 
 
UZ Gent   164 
UZ Antwerpen  50  
Sint Jan Brugge  26 
KU Leuven  93 
Sint Augustinus  35 
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Baseline characteristics 
  Total group 
n = 379 
Symptomatic 
n = 123 
Asymptomatic 
n = 256 
Total count 100% 32.5% 67.5% 
Sex           Boys 







Mean age at last 
follow-up (months) 
29.4 27.5 30.3 
Mean number of 
evaluations / child 
3.6 4.27  3.29 
Seroconversion 
       0-13 weeks 
       14-27 weeks 
       >27 weeks 
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Neonatal characteristics 
  TOTAL GROUP SYMPTOMATIC ASYMPTOMATIC 
Mean gestation (w) 
Mean birth weight (g) 
Mean birth length (cm) 













Reason for screening 
 Central imaging 
 Dysmaturity 
 Hearing loss 
 Known seroconversion 
 Developmental delay 
 Hematological    





























          60%                     84  
28% 
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Neonatal characteristics (2)  
  TOTAL GROUP SYMPTOMATIC ASYMPTOMATIC 
Ophthalmologic ex. 
  Normal 
  Abnormal 














  Normal 
  Unilateral hearing 
loss 
  Bilateral hearing loss  

















  No treatment 
  IV Ganciclovir 



















































Total group 74% 26% 
Symptomatic 37% 63% 
Asymptomatic 92% 8% 


































Total group 74% 26% 
Symptomatic 37% 63% 
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Delayed onset hearing loss 
  Total group Symptomatic Asymptomatic 
Mean age of 
diagnosis 
17.1m 14.6m 18.7m 
Percentiles           25 
                             50 










Range 2 – 61m 2 – 42m 3 – 61m 
  Total group Symptomatic Asymptomatic 
Patients 33 (8.7%) 13 (10.5%) 20 (7.8%)  
Ears 42 (5.5%) 17 (6.9%) 25 (4.9%) 
9%  11% 8% 
17.9m  20m 
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Delayed onset hearing loss 
  Total group Symptomatic Asymptomatic 
Mean age of 
diagnosis 
17.1m 14.6m 18.7m 
Percentiles           25 
                             50 










Range 2 – 61m 2 – 42m 3 – 61m 
  Total group Symptomatic Asymptomatic 
Patients 33 (8.7%) 13 (10.5%) 20 (7.8%)  
Ears 42 (5.5%) 17 (6.9%) 25 (4.9%) 
9%  11% 8% 
17.9m  20m 
23.8m  
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Delayed onset hearing loss: degree and laterality 
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0m 3m 6m 12m 18m 24m 30m 36m 48m 60m 72m 
Normal hearing,   






n = 144 
Asympto-
matic 











Stable 95 (66%) 22 (81.5%) 
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0m 3m 6m 12m 18m 24m 30m 36m 48m 60m 72m 
No fluctuations,  






n = 144 
Symptom-
atic 
n = 117 
Progression 37 (25.7%) 
33 
(28.2%) 
Improvement 12 (8.3%) 11 (9.4%) 
Stable 95 (66%) 73 (62.4%) 
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Hearing Amplification 
Total group Symptomatic Asymptomatic 
Hearing aid 
        unilateral 











        unilateral      










BAHA (as cros)  1 (0.3%) 1 (0.8%) 0 
Total with substitution 38 (10%) 35 (29.3%) 3 (1.2%) 
• In 100 cCMV children:  7 hearing aids 
   10 cochlear implants 
% % 
Neus-, keel- en oorheelkunde, Hoofd- en halschirurgie 
Conclusions 
Remarks: 
Our study: overrepresentation of symptomatic pts (referral bias) 
Changing definition:  More symptomatic children (33% <> 10%) 
      Less long-term sequelae in the asymptomatic group 
Hearing loss at final evaluation:  26% of total group 
     63% of symptomatic children 
     8% of asymptomatic children 
Degree: in case of HL 59% Profound (total group) 
Symptomatic group: majority with profound loss (65%) 
Asymptomatic group: majority with mild loss (48%), second largest group 
profound (33.3%) 
Laterality: 
Symptomatic group: unilateral losses = bilateral losses 
Asymptomatic group: more unilateral losses 
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Conclusions 
Delayed onset: 
9% of all children with cCMV (S>A, 11% <> 8%) 
Evolution to profound loss in 29% 
Mean age = 17 months 
50% before 14m, 75% before 24m 
Unstable nature with fluctuations > progressions > improvements 
More in symptomatic group 
 
 
LONGITUDINAL FOLLOW-UP = MANDATORY! 
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Thank you for your attention 
Questions? 
